The ACR & Rheumatology Research Foundation Are Transforming Our Specialty

Leading Boldly

The combined commitment of the ACR and the Foundation to the specialty has resulted in a significant increase in support for rheumatology research and education initiatives. When the Foundation launched its first-ever capital campaign, Within Our Reach: Finding a Cure for Rheumatoid Arthritis, the ACR demonstrated its commitment to the Foundation’s mission through unprecedented generosity. The ACR has since contributed more than $22.5 million to the Foundation. Without the ACR, the Foundation’s ability to expand funding for rheumatology research, education and training over the years would not have been possible. The ACR has led the way, and we must all ask ourselves, “If not us in rheumatology supporting the work of the Foundation, then who?”

Through partnerships and collaborations with the ACR and other healthcare leaders, the Foundation is working to transform rheumatology by advancing solutions that foster the continued development of new treatments and therapies, cultivating future generations of rheumatology professionals and providing patients with access to innovative treatments. Join us as we embark on this transformational initiative to shift the landscape of rheumatology. Visit the Foundation to discover how you can help us transform the lives of patients living with rheumatic diseases. 

Paula Marchetta, MD, MBA, is a rheumatologist in New York City and the CEO and managing partner of Concorde Medical Group, a multispecialty private group practice affiliated with NYU Langone Health. She teaches at NYU School of Medicine, where she is clinical professor. Dr. Marchetta is the 82nd President of ACR.

Abby Abelson, MD, FACR, chairs the Department of Rheumatology and Immunologic Disease at Cleveland Clinic and is president of the Rheumatology Research Foundation.